Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Coze

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Plos One|July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCNAnne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
Pediatric Blood & Cancer|May 18, 2016
Recurrence of Solid Pseudopapillary Neoplasms of the Pancreas: Results of a Nationwide Study of Risk Factors and Treatment ModalitiesSabine Irtan, Louise Galmiche-Rolland, Caroline Elie, et al.
Cancer|August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplificationAnne Laprie, Jean Michon, Olivier Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group StudyHervé Rubie, Julia Chisholm, Anne Sophie Defachelles, et al.
Pediatric Blood & Cancer|July 14, 2020
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experienceMorgane Pondrom, Gaelle Bougeard, Marie Karanian, et al.
Pediatric Blood & Cancer|August 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN StudyJulie Savagner, Caroline Munzer, Gudrun Schleiermacher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 22, 2015
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94Anne Ducassou, Marion Gambart, Caroline Munzer, et al.
British Journal of Cancer|May 15, 2018
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma StudyAna P Berbegall, Dominik Bogen, Ulrike Pötschger, et al.
Pediatric Blood & Cancer|October 10, 2024
Li-Fraumeni-associated osteosarcomas: The French experienceEmilie Saucier, Gaëlle Bougeard, Anne Gomez-Mascard, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Plos One|July 12, 2014
Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCNAnne Guimier, Sandrine Ferrand, Gaëlle Pierron, et al.
Pediatric Blood & Cancer|May 18, 2016
Recurrence of Solid Pseudopapillary Neoplasms of the Pancreas: Results of a Nationwide Study of Risk Factors and Treatment ModalitiesSabine Irtan, Louise Galmiche-Rolland, Caroline Elie, et al.
Cancer|August 27, 2004
High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplificationAnne Laprie, Jean Michon, Olivier Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group StudyHervé Rubie, Julia Chisholm, Anne Sophie Defachelles, et al.
Pediatric Blood & Cancer|July 14, 2020
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experienceMorgane Pondrom, Gaelle Bougeard, Marie Karanian, et al.
Pediatric Blood & Cancer|August 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN StudyJulie Savagner, Caroline Munzer, Gudrun Schleiermacher, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 22, 2015
Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94Anne Ducassou, Marion Gambart, Caroline Munzer, et al.
British Journal of Cancer|May 15, 2018
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma StudyAna P Berbegall, Dominik Bogen, Ulrike Pötschger, et al.
Pediatric Blood & Cancer|October 10, 2024
Li-Fraumeni-associated osteosarcomas: The French experienceEmilie Saucier, Gaëlle Bougeard, Anne Gomez-Mascard, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Pageof 6